List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 54 studies with search of: Open Studies | "Wilms Tumor"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting National Wilm's Tumor Study Late Effects
Condition: Wilm's Tumor
Intervention: Other: none, screening only
2 Recruiting Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Condition: Kidney Cancer
Interventions: Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
3 Recruiting Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Conditions: Kidney Cancer;   Precancerous/Nonmalignant Condition
Interventions: Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
4 Recruiting Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Condition: Kidney Cancer
Interventions: Biological: dactinomycin;   Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Radiation: radiation therapy
5 Recruiting Gene Expression Profiles to Categorize Wilms Tumors
Condition: Kidney Cancer
Intervention: Genetic: microarray analysis
6 Recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Condition: Kidney Cancer
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Radiation: radiation therapy
7 Recruiting Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Conditions: WAGR Syndrome;   Wilm's Tumor;   Aniridia;   Urogenital Abnormalities;   Mental Retardation
Intervention:
8 Recruiting WT1 Peptid Vaccination in Carcinomas
Condition: WT1 Expressing Carcinoma
Intervention: Biological: WT1 126-134 peptide
9 Recruiting Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML);   Leukemia, Acute Lymphocytic (ALL);   Leukemia, Chronic Myelogenous (CML);   Myelodysplastic Syndrome (MDS);   Non-Hodgkin's Lymphoma (NHL)
Interventions: Drug: WT1 Peptide-Pulsed Dendritic Cells;   Drug: Donor Lymphocytes;   Drug: IL-4;   Drug: KLH;   Drug: WT1 Peptides;   Drug: Endotoxin
10 Recruiting Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia
Condition: WT1-positive Acute Myeloid Leukemia
Intervention: Biological: GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI) GSK2130579A
11 Recruiting Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Conditions: Kidney Cancer;   Leukemia;   Lymphoma;   Neurotoxicity;   Sarcoma
Interventions: Dietary Supplement: glutamic acid;   Other: placebo
12 Recruiting WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome
Intervention: Biological: WT1 126-134 peptide
13 Recruiting Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
Condition: Leukemia
Intervention: Biological: WT-1
14 Recruiting Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
Conditions: Leukemia;   Myelodysplastic Syndrome
Intervention: Biological: WT1-sensitized T cells
15 Recruiting A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, and B Cell Malignancies
Conditions: Acute Myelogenous Leukemia (AML);   Chronic Myelogenous Leukemia (CML);   Acute Lymphoblastic Leukemia (ALL);   Myelodysplastic Syndrome (MDS);   B Cell Malignancies
Intervention: Biological: WT1 derived peptides
16 Not yet recruiting Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma
Conditions: Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Multiple Myeloma
Intervention: Biological: dendritic cell vaccination (active specific immunotherapy)
17 Recruiting Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers
Conditions: Myelodysplastic Syndrome (MDS);   Acute Myeloid Leukemia (AML);   Chronic Myeloid Leukemia (CML)
Interventions: Biological: WT1:126-134 Peptide;   Biological: PR1:169-177 Peptide;   Drug: GM-CSF (Sargramostim);   Drug: WT1 and PR1 Peptide Vaccines;   Biological: WT1 and PR1 Peptide Vaccines
18 Recruiting Study of Late-Occurring Complications in Childhood Cancer Survivors
Condition: Cancer
Interventions: Genetic: cytogenetic analysis;   Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: questionnaire administration
19 Recruiting Collecting and Storing Tissue From Young Patients With Cancer
Condition: Cancer
Interventions: Genetic: DNA analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis
20 Recruiting Study of Kidney Tumors in Young Patients
Conditions: Kidney Cancer;   Precancerous/Nonmalignant Condition
Interventions: Genetic: loss of heterozygosity analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: immunohistochemistry staining method;   Procedure: computed tomography;   Procedure: magnetic resonance imaging

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services